Westfield Capital Management CO LP Fate Therapeutics Inc Transaction History

Westfield Capital Management CO LP

$21.2 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$9.86 - $23.83 $50,867 - $122,938	-5,159 Reduced 0.37%	1,386,058 $14 Million
Q3 2022 Nov 14, 2022	SELL	$21.04 - $36.06 $8.48 Million - $14.5 Million	-403,031 Reduced 22.46%	1,391,217 $31.2 Million
Q2 2022 Aug 12, 2022	BUY	$17.78 - $42.39 $10.2 Million - $24.3 Million	573,927 Added 47.03%	1,794,248 $44.5 Million
Q1 2022 May 16, 2022	BUY	$29.67 - $60.28 $22 Million - $44.6 Million	740,673 Added 154.42%	1,220,321 $47.3 Million
Q4 2021 Feb 10, 2022	BUY	$47.84 - $64.34 $9.02 Million - $12.1 Million	188,547 Added 64.77%	479,648 $28.1 Million
Q3 2021 Nov 12, 2021	SELL	$59.27 - $95.73 $625,298 - $1.01 Million	-10,550 Reduced 3.5%	291,101 $17.3 Million
Q2 2021 Aug 10, 2021	BUY	$67.25 - $92.52 $3.02 Million - $4.16 Million	44,934 Added 17.5%	301,651 $26.2 Million
Q1 2021 May 14, 2021	BUY	$72.16 - $117.4 $7.01 Million - $11.4 Million	97,078 Added 60.81%	256,717 $21.2 Million
Q4 2020 Feb 12, 2021	SELL	$38.09 - $100.95 $9.55 Million - $25.3 Million	-250,690 Reduced 61.09%	159,639 $14.5 Million
Q3 2020 Nov 13, 2020	SELL	$30.41 - $40.5 $851,297 - $1.13 Million	-27,994 Reduced 6.39%	410,329 $16.4 Million
Q2 2020 Aug 13, 2020	BUY	$20.21 - $35.23 $530,047 - $923,977	26,227 Added 6.36%	438,323 $15 Million
Q1 2020 May 14, 2020	SELL	$17.28 - $31.88 $5.06 Million - $9.33 Million	-292,747 Reduced 41.53%	412,096 $9.15 Million
Q4 2019 Feb 13, 2020	SELL	$13.39 - $20.73 $2.69 Million - $4.16 Million	-200,776 Reduced 22.17%	704,843 $13.8 Million
Q3 2019 Nov 08, 2019	BUY	$15.47 - $22.5 $725,078 - $1.05 Million	46,870 Added 5.46%	905,619 $14.1 Million
Q2 2019 Aug 13, 2019	SELL	$15.61 - $20.44 $541,292 - $708,777	-34,676 Reduced 3.88%	858,749 $17.4 Million
Q1 2019 May 14, 2019	SELL	$13.15 - $18.71 $2.77 Million - $3.95 Million	-210,880 Reduced 19.1%	893,425 $15.7 Million
Q4 2018 Feb 08, 2019	BUY	$11.48 - $16.98 $3.13 Million - $4.62 Million	272,235 Added 32.72%	1,104,305 $14.2 Million
Q3 2018 Nov 14, 2018	BUY	$8.75 - $16.29 $232,837 - $433,476	26,610 Added 3.3%	832,070 $13.6 Million
Q2 2018 Aug 13, 2018	BUY	$9.16 - $13.48 $7.38 Million - $10.9 Million	805,460 New	805,460 $9.13 Million

Others Institutions Holding FATE

# of Institutions

177

Shares Held

113M

Call Options Held

53.7K

Put Options Held

Redmile Group, LLC San Francisco, CA

13.2M
Shares

$17.1 Million
3.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.4M
Shares

$13.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

10.1M
Shares

$13.2 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

5.57M
Shares

$7.24 Million
0.72% of portfolio
State Street Corp Boston, MA

5.25M
Shares

$6.83 Million
0.0% of portfolio

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $126M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.

Account